SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-029162
Filing Date
2020-03-04
Accepted
2020-03-04 16:16:36
Documents
81
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205287d1_10k.htm 10-K 1133320
2 EXHIBIT 4.1 tm205287d1_ex4-1.htm EX-4.1 26177
3 EXHIBIT 10.20 tm205287d1_ex10-20.htm EX-10.20 222389
4 EXHIBIT 10.21 tm205287d1_ex10-21.htm EX-10.21 14751
5 EXHIBIT 10.22 tm205287d1_ex10-22.htm EX-10.22 8698
6 EXHIBIT 21.1 tm205287d1_ex21-1.htm EX-21.1 1850
7 EXHIBIT 23.1 tm205287d1_ex23-1.htm EX-23.1 3380
8 EXHIBIT 31.1 tm205287d1_ex31-1.htm EX-31.1 8386
9 EXHIBIT 31.2 tm205287d1_ex31-2.htm EX-31.2 8364
10 EXHIBIT 32.1 tm205287d1_ex32-1.htm EX-32.1 4338
11 EXHIBIT 32.2 tm205287d1_ex32-2.htm EX-32.2 4080
18 GRAPHIC tm205287d1_10k-img001.jpg GRAPHIC 57145
19 GRAPHIC tm205287d1_10k-img002.jpg GRAPHIC 55446
20 GRAPHIC tm205287d1_10k-img003.jpg GRAPHIC 116540
21 GRAPHIC tm205287d1_10k-img004.jpg GRAPHIC 36418
  Complete submission text file 0001104659-20-029162.txt   6474294

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT eyeg-20191231.xml EX-101.INS 1267931
13 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20191231.xsd EX-101.SCH 44944
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20191231_cal.xml EX-101.CAL 57251
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20191231_def.xml EX-101.DEF 170655
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20191231_lab.xml EX-101.LAB 384452
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20191231_pre.xml EX-101.PRE 344025
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36672 | Film No.: 20687352
SIC: 2834 Pharmaceutical Preparations